| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 23, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 7,194 | $47.64 | $342,715.50 | -0.1% | |
| Nov 19, 2020 | DHR Danaher Corp /de/ | Rales Mitchell P70 | Chairman Of Exec. Committee | Buy | 26,784 | $226.14 | $6,056,933.76 | +1.1% | |
| Nov 19, 2020 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,500 | $46.57 | $349,272.42 | -0.2% | |
| Nov 18, 2020 | RDNT Radnet, Inc. | Murdock Michael N45 | Executive Vice President | Sell | 10,238 | $0.00 | - | -10.2% | |
| Nov 18, 2020 | PMDI Psychemedics Corp | Schaffer Michael I | VP Of Laboratory Operations | Buy | 500 | $4.20 | $2,100.00 | +1.9% | |
| Nov 18, 2020 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | Chief Operating Officer | Sell | 6,706 | $45.11 | $302,511.75 | -0.5% | |
| Nov 18, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 18,750 | $48.82 | $915,329.66 | -0.2% | |
| Nov 17, 2020 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 301 | $45.45 | $13,680.09 | - | |
| Nov 17, 2020 | FLGT Fulgent Genetics, Inc. | Bolger John C65 | Director | Sell | 4,269 | $44.24 | $188,876.78 | -91.9% | |
| Nov 17, 2020 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 103,767 | $46.14 | $4,788,185.63 | -12.9% | |
| Nov 16, 2020 | NEO Neogenomics Inc | Hipp Raymond R | Director | Sell | 70,000 | $42.28 | $2,959,600.00 | -51.2% | |
| Nov 16, 2020 | IQV Iqvia Holdings Inc. | Rittenmeyer Ronald A72 | Director | Sell | 40,792 | $174.35 | $7,112,085.20 | -65.5% | |
| Nov 16, 2020 | NEO Neogenomics Inc | Van Oort Douglas M | Chairman And CEO | Sell | 340,000 | $42.01 | $14,283,573.76 | -4.5% | |
| Nov 13, 2020 | PMDI Psychemedics Corp | Weinert Fred J | Director | Buy | 2,000 | $3.92 | $7,840.00 | +1.8% | |
| Nov 13, 2020 | PMDI Psychemedics Corp | Allen A Clinton | Director | Buy | 2,000 | $3.99 | $7,980.00 | +200.0% | |
| Nov 13, 2020 | NDRA Endra Life Sciences Inc. | Maloberti Renaud Bertrand | Chief Commercial Officer | Sell | 10,000 | $0.81 | $8,100.00 | -13.1% | |
| Nov 13, 2020 | CSTL Castle Biosciences Inc | Stokes Frank70 | Chief Financial Officer | Sell | 26,000 | $50.87 | $1,322,547.17 | -48.1% | |
| Nov 12, 2020 | VCYT Veracyte, Inc. | Gordon Kevin K51 | Director | Sell | 10,000 | $47.11 | $471,137.52 | -84.7% | |
| Nov 12, 2020 | WAT Waters Corp /de/ | Carson Robert G | SVP Corporate Development | Sell | 2,277 | $227.95 | $519,030.76 | -66.0% | |
| Nov 12, 2020 | CDNA Caredx, Inc. | Hagstrom William A61 | Director | Sell | 10,000 | $54.59 | $545,888.00 | -35.0% | |
| Nov 12, 2020 | PMDI Psychemedics Corp | Kubacki Raymond C Jr | Chairman, CEO &President | Buy | 2,000 | $3.86 | $7,720.00 | +0.5% | |
| Nov 11, 2020 | MYGN Myriad Genetics Inc | Phanstiel S. Louise62 | Director | Buy | 15,000 | $16.62 | $249,336.00 | +29.0% | |
| Nov 11, 2020 | VCYT Veracyte, Inc. | Ho Mark | Principal Accounting Officer | Sell | 13,875 | $45.00 | $624,375.00 | -42.1% | |
| Nov 11, 2020 | XGN Exagen Inc. | Hunt Holdings Limited Partnership | 10% Owner | Sell | 15,947 | $16.05 | $255,964.78 | -0.4% | |
| Nov 10, 2020 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 5,000 | $110.30 | $551,500.00 | -55.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.